EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Global Access to IMD Drugs: Bridging the Gap Between High‐Income Countries and Latin America

Juan Francisco Cabello iD, Rodrigo Salinas

Journal of Inherited Metabolic Disease · 2026

DOI: 10.1002/jimd.70152 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Inherited Metabolic Disease, 2026. Verfasst von Juan Francisco Cabello und 1 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Nutrición y Tecnología de los Alimentos (INTA), Universidad de Chile, Santiago, Chile. Hauptthemen laut MEDLINE: Health Services Accessibility, Orphan Drug Production, Rare Diseases. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

People living with inborn errors of metabolism (inherited metabolic diseases, IMDs) rely on lifesaving orphan drugs—therapies often developed and available primarily in high‐income countries. Yet in many low‐ and middle‐income regions, especially Latin America, patients face stark inequities in access. While an estimated 300 million people worldwide live with a rare disease, most Latin American countries until recently had little to no rare disease policy infrastructure [1]. This perspective highlights the disparity in IMD drug access between wealthy nations and Latin America (with Chile as a case in point), examines the ethical imperatives for equitable and timely access, and explores barriers and potential policy solutions to ensure no patient is left behind.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Health Services AccessibilityOrphan Drug ProductionRare DiseasesHumansLatin AmericaDeveloped CountriesDeveloping CountriesHealthcare Disparities

Autor:innen und Institutionen

  • Instituto de Nutrición y Tecnología de los Alimentos (INTA), Universidad de Chile, Santiago, Chile.
  • Departamento de Neurología, Universidad de Chile, Santiago, Chile.

ORCID-Profile: Juan Francisco Cabello

Zitieren

APA

Cabello, J. F., & Salinas, R. (2026). Global Access to IMD Drugs: Bridging the Gap Between High‐Income Countries and Latin America. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70152

Vancouver

Cabello JF, Salinas R. Global Access to IMD Drugs: Bridging the Gap Between High‐Income Countries and Latin America. Journal of Inherited Metabolic Disease. 2026. doi:10.1002/jimd.70152

BibTeX
@article{Cabello2026,
  author = {Cabello, Juan Francisco and Salinas, Rodrigo},
  title = {Global Access to IMD Drugs: Bridging the Gap Between High‐Income Countries and Latin America},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2026},
  doi = {10.1002/jimd.70152}
}
Kostenlos starten →